The impairment testing was done as at 31 December 2018. The methodology and assumptions used by GRR were also set out in Note 28. They will have done the testing (to comply with accounting standards) because the stockmarket valued GRR at less than the value of its non-current assets, the key ones of which are mines and PPE (about $270m).
In theory GRR represents a real bargain as at 31 December: audited net assets are $477m ($205m of that is cash) - against a mkt cap of about $300m. There is a gap:- if you trust the audited accounts (in particular the balance sheet/financial position) you can only assume that Mr Market has got it wrong. My opinion only...
- Forums
- ASX - By Stock
- GRR
- Is There an Impairment Coming
Is There an Impairment Coming, page-2
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GRR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.5¢ |
Change
0.010(4.26%) |
Mkt cap ! $266.1M |
Open | High | Low | Value | Volume |
23.5¢ | 24.5¢ | 23.5¢ | $94.40K | 393.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 30000 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 50299 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 219779 | 0.270 |
9 | 458580 | 0.265 |
26 | 932290 | 0.260 |
7 | 172530 | 0.255 |
22 | 717920 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.275 | 405759 | 8 |
0.280 | 942702 | 17 |
0.285 | 372332 | 13 |
0.290 | 1710676 | 31 |
0.295 | 651900 | 8 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
GRR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online